Royal Bank Of Canada Gilead Sciences, Inc. Transaction History

Royal Bank Of Canada

$471 Billion
Q3 2024

A detailed history of Royal Bank Of Canada transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Royal Bank Of Canada holds 6,672,888 shares of GILD stock, worth $591 Million. This represents 0.12% of its overall portfolio holdings.

Number of Shares

6,672,888

Previous 6,368,233 4.78%

Holding current value

$591 Million

Previous $437 Million 28.01%

% of portfolio

0.12%

Previous 0.1%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$66.59 - $83.99 $20.3 Million - $25.6 Million	304,655 Added 4.78%	6,672,888 $559 Million
Q2 2024 Nov 06, 2024	SELL	$63.15 - $72.88 $7.57 Million - $8.74 Million	-119,940 Reduced 1.85%	6,368,233 $437 Million
Q2 2024 Aug 14, 2024	SELL	$63.15 - $72.88 $46.6 Million - $53.8 Million	-737,732 Reduced 10.21%	6,488,173 $445 Million
Q1 2024 Nov 05, 2024	BUY	$71.58 - $87.29 $45.9 Million - $56 Million	641,747 Added 9.89%	7,129,920 $522 Million
Q1 2024 May 15, 2024	SELL	$71.58 - $87.29 $244 Million - $298 Million	-3,411,586 Reduced 32.07%	7,225,905 $529 Million
Q4 2023 Feb 14, 2024	SELL	$73.27 - $83.09 $13.9 Million - $15.8 Million	-189,734 Reduced 1.75%	10,637,491 $862 Million
Q3 2023 Nov 14, 2023	SELL	$73.94 - $80.67 $24.2 Million - $26.5 Million	-327,946 Reduced 2.94%	10,827,225 $811 Million
Q2 2023 Aug 14, 2023	BUY	$76.01 - $86.7 $69.2 Million - $78.9 Million	910,264 Added 8.89%	11,155,171 $860 Million
Q1 2023 May 15, 2023	SELL	$77.31 - $88.08 $84.6 Million - $96.4 Million	-1,094,612 Reduced 9.65%	10,244,907 $850 Million
Q4 2022 Feb 14, 2023	BUY	$62.32 - $89.47 $89.6 Million - $129 Million	1,437,260 Added 14.51%	11,339,519 $973 Million
Q3 2022 Nov 14, 2022	BUY	$59.54 - $68.01 $43.5 Million - $49.7 Million	730,795 Added 7.97%	9,902,259 $611 Million
Q2 2022 Aug 15, 2022	BUY	$57.72 - $65.01 $65.9 Million - $74.2 Million	1,141,771 Added 14.22%	9,171,464 $567 Million
Q1 2022 May 16, 2022	BUY	$57.92 - $72.58 $48.4 Million - $60.6 Million	835,010 Added 11.61%	8,029,693 $477 Million
Q4 2021 Feb 14, 2022	BUY	$64.88 - $73.64 $30.8 Million - $35 Million	475,162 Added 7.07%	7,194,683 $522 Million
Q3 2021 Nov 15, 2021	SELL	$67.69 - $73.03 $8.37 Million - $9.03 Million	-123,706 Reduced 1.81%	6,719,521 $469 Million
Q2 2021 Aug 16, 2021	BUY	$63.47 - $69.35 $434 Million - $475 Million	6,843,227 New	6,843,227 $471 Million

Others Institutions Holding GILD

# of Institutions

1,923

Shares Held

994M

Call Options Held

10.5M

Put Options Held

9.75M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $111B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

News

Stay updated on Royal Bank Of Canada with notifications on news.

Account

Royal Bank Of Canada Gilead Sciences, Inc. Transaction History